Clinical Diagnostics Solutions (CDS), a Boule Diagnostics company in the US, announces that its supply agreement with a leading global In Vitro Diagnostics (IVD) customer has been renewed and expanded. The extended agreement is a result of the trust in CDS and the work to innovate for diagnostic technologies worldwide.
The agreement is expected to increase sales by approximately SEK 5 million once the project is fully implemented in 2027 and have a good operating margin. This expansion strengthens Boule's strategic focus on long-term partnerships and profitable growth. "This agreement underlines the confidence in CDS's solutions and strengthens our role in advancing health diagnostics globally," says Torben Nielsen, CEO of Boule Diagnostics. “We look forward to continuing to deliver value and be a trusted supplier to our partners."